American Association for Cancer Research
Browse
23266066cir170204-sup-181983_3_supp_4477579_p1q786.pdf (401.13 kB)

Figure S2 from NK Cells Control Tumor-Promoting Function of Neutrophils in Mice

Download (401.13 kB)
journal contribution
posted on 2023-04-03, 23:22 authored by Keisuke Ogura, Marimo Sato-Matsushita, Seiji Yamamoto, Takashi Hori, Masakiyo Sasahara, Yoichiro Iwakura, Ikuo Saiki, Hideaki Tahara, Yoshihiro Hayakawa

Supplementary Figure 2. No alteration in the phenotype of tumor-infiltrated CTL.

Funding

MEXT

History

ARTICLE ABSTRACT

Although natural killer (NK) cells are recognized as direct antitumor effectors, the ability of NK cells to control cancer-associated inflammation, which facilitates tumor progression, remains unknown. In this study, we demonstrate that NK cells control tumor-promoting inflammation through functional modification of neutrophils. NK cells control the tumor-promoting function of neutrophils through an IFNγ-dependent mechanism. Tumor progression in an NK cell–depleted host is diminished when the IL17A–neutrophil axis is absent. In NK cell–depleted mice, neutrophils acquire a tumor-promoting phenotype, characterized by upregulation of VEGF-A expression, which promotes tumor growth and angiogenesis. A VEGFR inhibitor which preferentially suppressed tumor growth in NK cell–depleted mice was dependent on neutrophils. Furthermore, the systemic neutropenia caused by an antimetabolite treatment showed an anticancer effect only in mice lacking NK cells. Thus, NK cells likely control the tumor-promoting and angiogenic function of neutrophils. Cancer Immunol Res; 6(3); 348–57. ©2018 AACR.

Usage metrics

    Cancer Immunology Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC